Skip to content

Menu

Cote Law PLLC logo
HomeAboutServicesBlogContact
Search
Close

DEA Chronicles

Drug Enforcement Administration Litigation & Compliance Issues

Imodium A-D

Subscribe to Imodium A-D

FDA Approves New Packaging for “Poor Man’s Methadone”

By Larry P. Cote & Russell Day on September 22, 2019
Posted in Drug Policy, Overdose

While acknowledging the safety of the approved daily doses of OTC loperamide for adults (8mg per day) and prescription loperamide (16mg per day), the FDA recently approved new package-size and package-type limits for the brand-name OTC tablet and capsule forms of the drug. Here are the products affected by the FDA’s notice:

  • Imodium A-D

…

About this Blog

Welcome to DEA Chronicles, a blog dedicated to helping you comply with DEA requirements for controlled substance distribution and prescription dispensing — and all that comes along with it.

Read More....

Stay Connected

RSS LinkedIn Twitter

Topics

Archives

Recent Posts

  • A Distributor’s Conundrum: When DEA and state law collide
  • Congress Seeks to Provide Clarity on Suspicious Order Monitoring
  • DEA Issues New/Old Guidance on Suspicious Order Monitoring
  • New Software Platform for Controlled Substance Compliance
  • DEA to Remove Exemptions for All Butalbital Products
Cote Law PLLC logo

1875 K Street, NW • Fourth Floor • Washington, D.C, 20006
Office: (202) 507-5784 • Cell: (703) 298-2258 • Fax: (202) 379-9524

RSS LinkedIn Twitter
Copyright © 2023, Cote Law PLLC. All Rights Reserved.
DisclaimerPrivacy Policy
Law blog design & platform by LexBlog LexBlog Logo